ANEUVO is a platform therapy development company focused on development of disruptive neuromodulation technologies.
ANEUVO has raised $22.0M in total funding. The most recent round was Series C. The last funding was announced in March 2026.
ANEUVO's investors include National Science Foundation, CATCHER TECHNOLO RG.
ANEUVO is headquartered in Los Angeles, United States.
ANEUVO is a platform therapy development company focused on development of disruptive neuromodulation technologies.
ANEUVO is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ANEUVO — Funding & Investors." VCBacked, March 5, 2026, https://www.vcbacked.co/company/aneuvo. Accessed August 14, 2026.
VCBacked. (2026). ANEUVO — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aneuvo
{{cite web |title=ANEUVO — Funding & Investors |url=https://www.vcbacked.co/company/aneuvo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated